Full Text
Cost-effectiveness of universal versus assay-driven antiplatelet therapy in acute coronary syndrome patients

Abstract

Authors

C.I. Coleman B.L. Limone

Back to Volume 16, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×